About this trial
This study aims to evaluate the intra- and inter-rater reliability of the MyotonPRO, a handheld device that measures the viscoelastic properties of the skin, in patients with breast cancer-related lymphedema. Twenty women with unilateral upper extremity lymphedema will be included. Each participant will undergo repeated skin assessments using the MyotonPRO by two independent raters. Additionally, ultrasonographic tissue characteristics and limb volume measurements will be performed. The findings are expected to contribute to the validation of the MyotonPRO for use in clinical lymphedema evaluation.
Eligibility criteria
Qualifiers
Female participants aged 18-80 years
Unilateral upper extremity lymphedema secondary to breast cancer surgery
Diagnosed with lymphedema at International Society of Lymphology (ISL) Stage 0, I, II, or III
Willing and able to provide informed consent
Disqualifiers
Bilateral upper extremity lymphedema
Cognitive or mental disorders that interfere with cooperation
Neurological diseases
Active infection
Trial design
Treatments tested in this trial
- MyotonPRO
Treatment groups
Locations
Sponsors and collaborators
Kahramanmaras Sutcu Imam University
Lead sponsor
Fatih Sultan Mehmet Training and Research Hospital
Collaborator